Today’s top gainers include the company Abbott Laboratories (NYSE:ABT) which is in the industry Medical Appliances & Equipment, gaining -0.50% today. In the last week its performance is -2.07%, and 8.12% for the past quarter. Currently, Abbott Laboratories, ABT has a target price of 48, so today’s gain of -0.50% is a significant step towards its target price. The GAP today is therefore 0.14%.
Abbott Laboratories (NYSE:ABT), has a market cap of 62180.82, and is based in USA. Insider ownership is at 0.30%, and institutional ownership is 73.90%.
At the current price of 42.09, it has a dividend yield of 2.47%, and its target price is 48. This is with a profit margin of 11.10%, and total debt/equity of 0.41. Abbott Laboratories (NYSE:ABT) has a P/E of 32.3, as well as a forward P/E of 17.11.
With a current EPS of 1.3, and a forecasted EPS growth for next year at 11.87%,Abbott Laboratories (NYSE:ABT) has had a EPS growth for the past five years at -10.30%. For the next five years EPS growth is projected to be 9.36%.
Performance for the year is -2.30%. Since its IPO date on 4/6/1983, the total performance to date is -4.53%.
Volume today for Abbott Laboratories (NYSE:ABT), is 7189100, while its average volume is 10232. Whilst the total gain today was -0.50%, it did have a day high of -8.08%.
Volatility for this week has been at 1.72%, and 1.54% for the month. The 52-week low for Abbott Laboratories, ABT has been 18.36%, while the 52-week-high has reached -8.08%.
Looking at its return of investments, which is 7.70%, and its return on assets is 5.60%. Abbott Laboratories (NYSE:ABT) has an operating margin of 14.00%. With a sales growth of 3.20% quarter over quarter. Bearing in mind that Abbott Laboratories, ABT is in the sector Healthcare, its long-term debt/equity is 0.29, and has a current ratio of 1.5 and 1.2 for quick ratio.
So what is the value of Abbott Laboratories? Well its PEG is 3.45, and the P/S is 3.02, along with a P/B of 3. Meanwhile it has a p/cash of 14.01.